Pfizer Inc. (NYSE:PFE)

The period under review demonstrates significant fluctuations in Return on Invested Capital (ROIC). Initial values indicate strong performance, followed by a substantial decline and subsequent, modest recovery.

Net Operating Profit After Taxes (NOPAT)

NOPAT increased considerably from 2021 to 2022, more than doubling. However, 2023 witnessed a dramatic reversal, resulting in a substantial net loss. NOPAT recovered in 2024 and 2025, but remained below the 2022 peak. The volatility in NOPAT is a primary driver of the observed ROIC trends.

Invested Capital

Invested capital exhibited a consistent upward trend from 2021 to 2023, nearly doubling over the period. A decrease was observed in 2024, followed by a slight increase in 2025. While generally increasing, the growth rate of invested capital did not consistently align with the fluctuations in NOPAT, impacting ROIC.

Return on Invested Capital (ROIC)

ROIC followed a pattern mirroring NOPAT. A strong ROIC of 20.98% in 2021 increased to 28.01% in 2022. The negative NOPAT in 2023 resulted in a significantly negative ROIC of -0.82%. ROIC improved to 5.45% in 2024 and 5.15% in 2025, indicating a recovery, but remaining substantially below the levels achieved in 2021 and 2022. The decline in ROIC from 2022 to 2023 is particularly noteworthy, suggesting a significant shift in profitability relative to capital employed.

The substantial decline in ROIC during 2023 warrants further investigation to understand the underlying causes of the NOPAT loss. While a recovery is evident in the subsequent two years, the ROIC remains considerably lower than its previous high, indicating a potential shift in the company’s operational efficiency or competitive landscape.

The period under review demonstrates significant fluctuations in the components of return on invested capital. A notable divergence emerges when examining operating profit margin, capital turnover, and the impact of the effective cash tax rate on overall ROIC.

Operating Profit Margin (OPM)

The operating profit margin exhibited a substantial increase from 29.86% in 2021 to 38.53% in 2022. However, this was followed by a dramatic decline to 1.40% in 2023. A partial recovery is then observed in 2024 and 2025, with margins stabilizing at 15.40% and 15.22% respectively. This suggests a period of exceptional profitability followed by significant challenges, and then a moderate rebound.

Turnover of Capital (TO)

The turnover of capital remained relatively stable between 2021 and 2022, at 0.94 and 0.91 respectively. A sharp decrease is then evident in 2023, falling to 0.38, indicating a substantial reduction in the efficiency of capital utilization. A modest improvement occurs in 2024 (0.47) and 2025 (0.45), but levels remain considerably lower than those observed in the earlier period. This suggests a significant change in how effectively the company generates revenue from its capital base.

Effective Cash Tax Rate (CTR)

The value of 1 – Effective cash tax rate was consistently high in 2021 and 2022 (74.98% and 79.56% respectively), indicating a relatively low effective tax burden. However, a highly unusual and negative value of -152.75% is recorded in 2023, which likely reflects a significant tax benefit or accounting adjustment. The rate returns to a more conventional level in 2024 and 2025, at 75.24% and 75.50% respectively. This volatility significantly impacts the after-tax profitability reflected in ROIC.

Return on Invested Capital (ROIC)

The ROIC followed a pattern consistent with the interplay of the aforementioned factors. It rose from 20.98% in 2021 to 28.01% in 2022, mirroring the improvements in both OPM and TO. The substantial decline in OPM and TO, coupled with the anomalous CTR, resulted in a negative ROIC of -0.82% in 2023. A partial recovery is seen in 2024 and 2025, with ROIC reaching 5.45% and 5.15% respectively, but these levels remain significantly below the peak observed in 2022. The overall trend indicates a substantial deterioration in capital efficiency and profitability, followed by a limited recovery.

The substantial fluctuations observed, particularly in 2023, warrant further investigation to understand the underlying drivers and their potential implications for future performance.

The operating profit margin exhibited significant fluctuations over the observed period. Initial values were strong, followed by a substantial decline and a subsequent partial recovery.

Operating Profit Margin (OPM) - Overall Trend

The operating profit margin began at 29.86% in 2021, increasing to a peak of 38.53% in 2022. A dramatic decrease followed, with the margin falling to 1.40% in 2023. A recovery was then noted in 2024 and 2025, reaching 15.40% and 15.22% respectively, though remaining considerably below the levels seen in 2021 and 2022.

The net operating profit before taxes mirrored the OPM trend, peaking in 2022 at US$38,985 million before a sharp reduction to US$836 million in 2023. Subsequent years showed increases, reaching US$9,801 million in 2024 and US$9,527 million in 2025.

Revenue Trend

Revenues increased from US$82,145 million in 2021 to US$101,175 million in 2022. A substantial decline occurred in 2023, with revenues falling to US$59,553 million. Revenues experienced modest growth in 2024 and 2025, reaching US$63,627 million and US$62,579 million, respectively. The revenue decline in 2023 likely contributed to the significant drop in the operating profit margin observed in that year.

The substantial decrease in both net operating profit before taxes and the operating profit margin in 2023 warrants further investigation. While revenues decreased, the disproportionate drop in profitability suggests potential factors such as increased costs of goods sold, higher operating expenses, or changes in product mix may have played a significant role. The partial recovery in 2024 and 2025 indicates some stabilization, but the OPM remains significantly lower than its earlier levels.

The period under review demonstrates significant fluctuations in the turnover of capital. Revenues initially increased, followed by a substantial decline, while invested capital exhibited a different pattern. This interplay significantly impacted the calculated turnover ratio.

Revenue Trend

Revenues increased from US$82,145 million in 2021 to US$101,175 million in 2022, representing a growth of approximately 23.1%. However, a marked decrease occurred in 2023, with revenues falling to US$59,553 million. A partial recovery was observed in 2024, reaching US$63,627 million, followed by a slight decrease to US$62,579 million in 2025. This suggests potential volatility in sales or a shift in revenue generation strategies.

Invested Capital Trend

Invested capital increased consistently from US$87,670 million in 2021 to US$154,882 million in 2023, indicating a period of significant capital deployment. A decrease was then noted in 2024, with invested capital falling to US$135,342 million, and a further increase to US$139,753 million in 2025. This pattern could reflect strategic investments, divestitures, or changes in working capital management.

Turnover of Capital (TO) Analysis

The turnover of capital ratio, which measures how efficiently invested capital is used to generate revenue, began at 0.94 in 2021 and decreased to 0.91 in 2022. A substantial decline was then observed in 2023, with the ratio falling to 0.38. A modest improvement occurred in 2024, reaching 0.47, but this was followed by a slight decrease to 0.45 in 2025. The significant drop in 2023 aligns with the substantial decrease in revenues, while the increase in invested capital further exacerbated the decline in the ratio. The subsequent increases in 2024 and 2025, while modest, suggest a potential stabilization, though the ratio remains considerably lower than the levels observed in 2021 and 2022.

The divergence between revenue and invested capital trends resulted in a significantly reduced turnover of capital. Further investigation into the drivers of these trends is warranted to understand the underlying operational and strategic factors influencing capital efficiency.

The relationship between cash operating taxes, net operating profit before taxes, and the resulting effective cash tax rate exhibits significant fluctuations over the observed period. A substantial divergence in the effective cash tax rate is apparent, particularly in 2023.

Cash Operating Taxes

Cash operating taxes increased from US$6,137 million in 2021 to US$7,967 million in 2022, representing a growth of approximately 29.9%. However, these taxes decreased dramatically to US$2,113 million in 2023, followed by a modest increase to US$2,426 million in 2024 and US$2,334 million in 2025. This suggests a considerable volatility in actual cash tax payments.

Net Operating Profit Before Taxes (NOPBT)

Net operating profit before taxes experienced a significant increase from US$24,532 million in 2021 to US$38,985 million in 2022, a rise of roughly 59.1%. A sharp decline occurred in 2023, with NOPBT falling to US$836 million. Subsequent years show recovery, reaching US$9,801 million in 2024 and US$9,527 million in 2025, though remaining below the 2021 and 2022 levels.

Effective Cash Tax Rate (CTR)

The effective cash tax rate was 25.02% in 2021 and decreased to 20.44% in 2022. A dramatic spike to 252.75% occurred in 2023, coinciding with the substantial decrease in NOPBT. This exceptionally high rate indicates that the relatively small amount of cash taxes paid in 2023 was levied against a very low profit base. The rate then decreased to 24.76% in 2024 and 24.50% in 2025, stabilizing within a range close to the 2021 level. The volatility in the CTR is directly linked to the fluctuations in NOPBT, particularly the significant decline observed in 2023.

The substantial changes in both NOPBT and cash operating taxes, and consequently the CTR, warrant further investigation to understand the underlying drivers. The 2023 anomaly, in particular, requires detailed analysis to determine the factors contributing to the exceptionally high effective cash tax rate.